fluorodeoxyglucose f18 has been researched along with Airflow Obstruction, Chronic in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 13 (65.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Basu, S; Kalshetty, A | 1 |
Schlehr, E; Schlehr, JM; Sinha, P; Sinha, S | 1 |
Chalela, R; Gea, J; Martínez-Llorens, J; Orozco-Levi, M; Pascual, S; Sancho-Muñoz, A; Trampal, C | 1 |
Bucerius, J; Franssen, FM; Mottaghy, FM; van Kroonenburgh, MJ; van Meerendonk, AM; Vanfleteren, LE; Wouters, EF | 1 |
Alavi, A; Choi, GG; Ciftci, E; Han, Y; Salavati, A; Torigian, D; Werner, TJ; Weston, B | 1 |
Bailly, P; Daouk, J; Jounieaux, V; Kamimura, M; Meyer, ME; Sacksick, D | 1 |
Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT | 1 |
Chen, DL; Goo, JM; Schiebler, ML; van Beek, EJR | 1 |
Foster, CC; Hagge, RJ; Lin, FI; Shelton, DK | 1 |
Ball, DL; Binns, D; Ding, Z; Herschtal, A; Hicks, RJ; Hogg, A; Mac Manus, MP | 1 |
Bolton, CE; Cockcroft, JR; Coulson, JM; Duckers, JM; Rees, JI; Rudd, JH; Shale, DJ | 1 |
Muzaffar, R; Osman, MM; Parkar, N; Ruppel, GL; Sachdeva, A; Tran, IT | 1 |
Gholamrezanezhad, A | 1 |
Edgar, R; Jenkins, L; Parr, DG; Quraishi, N; Stockley, RA; Subramanian, DR | 1 |
Angoue, O; Boulahdour, H; Moulin, V; Ojeda-Uribe, M; Porot, C; Thiebault, S; Ungureanu, C | 1 |
Alavi, A; Kwee, TC; Torigian, DA | 1 |
Jones, HA; Marino, PS; Morrell, NW; Shakur, BH | 1 |
Dirksen, A; Eigtved, A; Fischer, BM; Højgaard, L; Mortensen, J | 1 |
Alavi, A; Aydin, A; Hickeson, M; Yu, JQ; Zhuang, H | 1 |
Floresca, J; Graham, MM; Juweid, M; Malik, J; Menda, Y; Reddy, MP | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Airflow Obstruction, Chronic
Article | Year |
---|---|
PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises.
Topics: Arteritis; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Lupus Erythematosus, Systemic; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Thoracic Diseases | 2020 |
FDG-PET/CT in Infectious and Inflammatory Diseases.
Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism | 2014 |
PET imaging approaches for inflammatory lung diseases: Current concepts and future directions.
Topics: Asthma; Fluorodeoxyglucose F18; Humans; Peptides; Pneumonia; Polyethylene Glycols; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Radiopharmaceuticals | 2017 |
Nononcological applications of positron emission tomography for evaluation of the thorax.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Infections; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiratory Distress Syndrome; Sarcoidosis; Thoracic Diseases; Thorax | 2013 |
4 trial(s) available for fluorodeoxyglucose f18 and Airflow Obstruction, Chronic
Article | Year |
---|---|
Positron emission tomography-based evidence of low-amplitude respiratory motion in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Emphysema; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Motion; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiration; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study.
Topics: Aged; Aorta; Arteritis; Fluorodeoxyglucose F18; Humans; Male; Metabolic Syndrome; Middle Aged; Pilot Projects; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Smoking | 2010 |
Positron emission tomography of incidentally detected small pulmonary nodules.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2004 |
Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease.
Topics: Abdominal Muscles; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Statistics as Topic; Thorax; Tissue Distribution | 2005 |
12 other study(ies) available for fluorodeoxyglucose f18 and Airflow Obstruction, Chronic
Article | Year |
---|---|
COVID-19: Incidental Diagnosis by 18F-FDG PET/CT.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Fluorodeoxyglucose F18; Humans; Male; Neoplasms; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2 | 2020 |
Muscle glucose metabolism in chronic obstructive pulmonary disease patients.
Topics: Aged; Blood Glucose; Cross-Sectional Studies; Diaphragm; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Pulmonary Disease, Chronic Obstructive; Quadriceps Muscle; Radiopharmaceuticals; Rectus Abdominis; Retrospective Studies; Spirometry; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study.
Topics: Aged; Aorta, Abdominal; Aortitis; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Intra-Abdominal Fat; Male; Pilot Projects; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Retrospective Studies; Subcutaneous Fat, Abdominal; Vital Capacity | 2014 |
Metabolic effects of pulmonary obstruction on myocardial functioning: a pilot study using multiple time-point 18F-FDG-PET imaging.
Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2015 |
Extensive FDG uptake in accessory muscles of respiration in a patient with shortness of breath.
Topics: Abdominal Muscles; Aged; Dyspnea; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 2011 |
Does ¹⁸F-FDG uptake by respiratory muscles on PET/CT correlate with chronic obstructive pulmonary disease?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; Respiratory Muscles; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2011 |
Respiratory muscle (18)F-FDG uptake.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Pulmonary Disease, Chronic Obstructive; Radionuclide Imaging; Respiratory Muscles | 2012 |
Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.
Topics: Aged; alpha 1-Antitrypsin Deficiency; Bronchitis; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; Neutrophil Activation; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Reference Values; Respiratory Function Tests; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed; United Kingdom | 2012 |
Intrathoracic extramedullary haematopoiesis: the advantages of hybrid imaging.
Topics: Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematopoiesis, Extramedullary; Humans; Hypoxia; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Thoracic Vertebrae; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma.
Topics: Aged; Analysis of Variance; Asthma; Case-Control Studies; Cell Count; Female; Fluorodeoxyglucose F18; Humans; Isoquinolines; Macrophages; Male; Middle Aged; Neutrophils; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sputum; Tomography, Emission-Computed | 2003 |
FDG positron emission tomographic imaging of pseudo-pseudo tumor.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Diagnosis, Differential; Dyspnea; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Plasma Cell Granuloma, Pulmonary; Pulmonary Disease, Chronic Obstructive; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma | 2002 |